Argent BioPharma Ltd (ASX:RGT) Managing Director and CEO of Argent BioPharma Roby Zomer joins DirectorsTalk Interviews to discuss its Quarter Activity Report published to the market.
In this interview Roby explains why a comprehensive restructuring process was undertaken and what is different, how the company product portfolio is performing, the addition of Dr. Shlomo Sadoun to the advisory board and how Roby sees the outlook for Argent BioPharma.
Argent BioPharma Ltd, is an Australia-based drug discovery company focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies.
